David E Newby Selected Research

ferric oxide (iron oxide)

1/2021	Diagnostic Applications of Ultrasmall Superparamagnetic Particles of Iron Oxide for Imaging Myocardial and Vascular Inflammation.
2/2019	MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease.
1/2019	Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation.
1/2019	Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy.
1/2018	Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis.
12/2017	Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery.
12/2017	Exploring the Biological and Mechanical Properties of Abdominal Aortic Aneurysms Using USPIO MRI and Peak Tissue Stress: A Combined Clinical and Finite Element Study.
10/2017	Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction.
1/2016	Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T.
9/2015	Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David E Newby Research Topics

Disease

70	Myocardial Infarction 07/2022 - 09/2002
41	Inflammation (Inflammations) 12/2022 - 01/2003
33	Thrombosis (Thrombus) 01/2022 - 01/2003
32	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 04/2003
30	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 02/2004
30	Heart Failure 01/2022 - 09/2002
29	Acute Coronary Syndrome 07/2022 - 07/2008
28	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 03/2004
21	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 12/2007
19	Atherosclerotic Plaque (Atheroma) 01/2022 - 08/2003
18	Fibrosis (Cirrhosis) 12/2021 - 07/2003
17	Atherosclerosis 12/2022 - 12/2005
16	Coronary Disease (Coronary Heart Disease) 07/2022 - 03/2006
15	Calcinosis 06/2022 - 07/2015
11	Rupture 10/2022 - 07/2007
11	Infarction (Infarctions) 01/2022 - 09/2011
11	Stroke (Strokes) 01/2022 - 12/2010
10	Abdominal Aortic Aneurysm 06/2022 - 05/2011
10	Pathologic Constriction (Stenosis) 10/2020 - 01/2003
9	Aneurysm (Aneurysms) 11/2021 - 05/2011
8	Disease Progression 01/2022 - 01/2013
8	Chest Pain (Chest Pains) 01/2021 - 05/2012
7	Death (Near-Death Experience) 01/2021 - 12/2015
6	Vascular Diseases (Vascular Disease) 01/2021 - 11/2008
6	Hemorrhage 01/2021 - 04/2007
6	Necrosis 11/2019 - 03/2006
5	Hypertension (High Blood Pressure) 01/2022 - 12/2005
5	Hypertrophy 01/2020 - 07/2010
5	Pneumonia (Pneumonitis) 10/2017 - 01/2009
5	Myocardial Ischemia (Ischemic Heart Diseases) 04/2017 - 09/2002
5	Vascular System Injuries 01/2014 - 03/2003
4	Aortic Valve Disease 10/2021 - 04/2012
4	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 11/2019
4	ST Elevation Myocardial Infarction 01/2021 - 01/2006
4	Vascular Calcification 01/2020 - 04/2016
4	Reperfusion Injury 01/2016 - 11/2011
3	Left Ventricular Dysfunction 01/2022 - 04/2005
3	Type 2 Diabetes Mellitus (MODY) 02/2021 - 01/2016
3	Heart Diseases (Heart Disease) 01/2021 - 12/2016
3	Stable Angina 01/2018 - 02/2014
3	Chronic Limb-Threatening Ischemia 01/2017 - 07/2010
3	Ischemia 01/2017 - 07/2012

Drug/Important Bio-Agent (IBA)

38	TroponinIBA 07/2022 - 04/2010
29	FluoridesIBA 11/2022 - 01/2012
28	Troponin IIBA 01/2022 - 04/2010
25	Biomarkers (Surrogate Marker)IBA 12/2022 - 02/2004
25	CalciumIBA 07/2022 - 04/2012
20	GadoliniumIBA 01/2022 - 09/2011
13	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2021 - 09/2002
13	ferric oxide (iron oxide)IBA 01/2021 - 05/2011
12	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2021 - 05/2011
11	BradykininIBA 03/2017 - 09/2002
10	Phenobarbital (Luminal)FDA Link 10/2020 - 08/2003
10	Vehicle Emissions (Emissions, Vehicle)IBA 01/2018 - 09/2007
9	C-Reactive ProteinIBA 12/2022 - 01/2006
9	vilanterolIBA 02/2019 - 05/2013
9	fluticasone furoate FDA Link 02/2019 - 05/2013
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2012
7	Biological ProductsIBA 01/2022 - 10/2013
7	LipidsIBA 01/2021 - 06/2005
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 04/2016
7	SmokeIBA 12/2014 - 07/2008
6	Proteins (Proteins, Gene)FDA Link 02/2021 - 04/2012
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2008 - 09/2002
5	ApelinIBA 12/2022 - 05/2008
5	SodiumIBA 06/2022 - 07/2003
5	Particulate MatterIBA 03/2015 - 06/2008
5	OzoneIBA 03/2015 - 12/2010
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2005 - 09/2002
4	Interleukin-6 (Interleukin 6)IBA 12/2022 - 07/2010
4	Sodium Fluoride (Ossin)FDA Link 10/2022 - 01/2020
4	ElastinIBA 01/2022 - 12/2007
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 11/2007
4	N 30IBA 01/2022 - 09/2010
4	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 12/2007
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2008
4	P-SelectinIBA 01/2019 - 07/2010
4	CytokinesIBA 01/2019 - 04/2003
4	Air Pollutants (Pollutants, Air)IBA 12/2017 - 09/2013
4	erucylphosphocholineIBA 01/2014 - 06/2010
4	KininsIBA 03/2012 - 04/2005
3	Endothelin-1 (Endothelin 1)IBA 12/2022 - 11/2004
3	ManganeseIBA 01/2022 - 01/2020
3	Oxygen (Dioxygen)IBA 01/2022 - 07/2008
3	Nitrogen DioxideIBA 01/2022 - 09/2013
3	Denosumab FDA Link 11/2021 - 05/2015
3	AcidsIBA 11/2021 - 03/2017
3	FibrinIBA 11/2020 - 11/2010
3	Ferrosoferric Oxide (Magnetite)FDA Link 12/2019 - 10/2017
3	Contrast MediaIBA 12/2019 - 03/2004
3	Clopidogrel (Plavix)FDA Link 01/2018 - 07/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 06/2005
3	UrocortinsIBA 10/2016 - 08/2010
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 02/2016 - 04/2012

Therapy/Procedure

46	Therapeutics 07/2022 - 09/2002
8	Stents 01/2021 - 01/2003
7	Percutaneous Coronary Intervention 01/2020 - 01/2003
4	Length of Stay 01/2021 - 11/2007
3	Carotid Endarterectomy 01/2019 - 02/2014
3	Intra-Arterial Infusions 04/2017 - 10/2016